About EurexOTC Clear
EMIR 3.0 - active account
CCP Switch
On-boarding
Compression Service
Product Scope
Interest Rate Swaps
Inflation Swaps
Settlement Prices
Service Offering for PSAs
Clearing Member
ISA Direct Member
ISA Direct Light Licence Holder
Clearing Agent
Client
Jurisdictions
Multiple Clearing Relationships
Segregation Set up
Cross-Project-Calendar
Readiness for projects
C7 Releases
C7 SCS Releases
C7 CAS Releases
EurexOTC Clear Releases
Prisma Releases
Member Section Releases
Simulation calendar
Archive
User ID Maintenance
Clearing Hours
Clearing Reports
Product Specifications
Clearing on behalf
Delivery Management
Transaction Management
Collateral Management
Collateral
Transparency Enabler Files
Segregation Models
Reports
Default Fund
Intraday Margin Calls
OTC Clear Procedures
OTC Clear Tutorials
Cross Margining Support
Supplementary Margins
Default Waterfall
Model Validation
Stress testing
Default Management Process
Client Asset Protection under EMIR
Client Asset Protection under LSOC
Credit, concentration & wrong way risk
System-based risk controls
Pioneering CCP Transparency
Haircut and adjusted exchange rates
Securities margin groups and classes
Prices Rolling Spot Future
File services
Bond Clusters
Listed derivatives
OTC derivatives
Listed securities
Cash management
Delivery management
CCP eligible instruments
Eurex Newsletter Subscription
Circulars & Newsflashes Subscription
Corporate Action Information Subscription
Circulars & Readiness Newsflashes
News
Videos
Webcasts on demand
Publications
Forms
Events
FAQs
Production Newsboard
Eurex | Eurex Clearing | Eurex Group
Global equity markets saw an impressive bounce back as investors chose to look towards positive data points on infection rates and vaccine hopes emerged. The initial leg of this rally came immediately after the first large quarterly expiry of the year, indicative that derivative positioning may have been a significant factor in triggering this short-term support. Volumes at Eurex remained elevated compared to the same month last year as on-going hedging demand was evident across our benchmark products: EURO STOXX 50®, Banks® sector, STOXX Europe 600®, Mini-DAX and SMI® Futures. Unsurprisingly, given the recent market turmoil having a direct impact on company decisions to postpone 2019 dividend payments, volatile forward pricing has been a challenge for all our members. This has translated into heavy demand to hedge equity repo exposure via our EURO STOXX 50® Total Return Future and, of course, the related EURO STOXX 50® index dividend futures & options where prices have already rebounded from historically low levels.
In other asset classes, the distressed market conditions took longer to materialize. We saw this in the WTI crude oil May futures contract, where we experienced negative prices for the first time in history. This poses a major headache for risk managers all over the market, looking to cover feasible stress scenarios. With implied volatility levels still high, clients have notably utilized shorter-dated expiries that are less Vega risk heavy to execute index hedges. This was particularly seen in the EURO STOXX 50® and Banks® sector weekly index options that saw an uplift in activity. There was also a strong increase in MSCI index options as open interest builds in MSCI EM, World and EAFE.
The strong market performance in April is not without detractors who point to the relatively lower cash volumes that have taken equities broadly higher but also the diplomatic rapprochements that are already rumbling in the background, again seeing the U.S. facing off China. Now that the world slowly begins the process of lifting lockdown restrictions, new, and sobering, questions rise along. How will small businesses survive? How will the U.S. bring 30 million jobs back? And, how will the immense central bank liquidity injections burden taxpayers? Typically, the market intensely dislikes uncertainties and so derivative hedging demand will likely continue in the subsequent weeks and months ahead.